OpenURL Connection Search

Select item for more details and to access through your institution.

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes.
Published in:
Arthritis Research & Therapy, 2018, v. 20, n. 1, p. 1, doi. 10.1186/s13075-018-1541-z
By:
- Genovese, Mark;
- Westhovens, Rene;
- Meuleners, Luc;
- Van der Aa, Annegret;
- Harrison, Pille;
- Tasset, Chantal;
- Kavanaugh, Arthur
Publication type:
Article
Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor.
Published in:
British Journal of Clinical Pharmacology, 2018, v. 84, n. 12, p. 2779, doi. 10.1111/bcp.13726
By:
- Namour, Florence;
- Fagard, Liesbeth;
- Van der Aa, Annegret;
- Harrison, Pille;
- Xin, Yan;
- Tasset, Chantal
Publication type:
Article
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Published in:
Rheumatology, 2022, v. 61, n. 5, p. 2063, doi. 10.1093/rheumatology/keab543
By:
- Maksymowych, Walter P;
- Østergaard, Mikkel;
- Landewé, Robert;
- Barchuk, William;
- Liu, Ke;
- Tasset, Chantal;
- Gilles, Leen;
- Hendrikx, Thijs;
- Besuyen, Robin;
- Baraliakos, Xenofon
Publication type:
Article
Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR).
Published in:
Rheumatology, 2020, v. 59, n. 7, p. 1495, doi. 10.1093/rheumatology/kez408
By:
- Orbai, Ana-Maria;
- Ogdie, Alexis;
- Gossec, Laure;
- Tillett, William;
- Leung, Ying Ying;
- Gao, Jingjing;
- Trivedi, Mona;
- Tasset, Chantal;
- Meuleners, Luc;
- Besuyen, Robin;
- Hendrikx, Thijs;
- Coates, Laura C
Publication type:
Article
086 Safety and efficacy of filgotinib in a phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic disease modifying anti-rheumatic drugs.
Published in:
2019
By:
- Walker, David;
- Genovese, Mark C;
- Kalunian, Kenneth;
- Gottenberg, Jacques-Eric;
- Vlam, Kurt de;
- Mozaffarian, Neelufar;
- Bartok, Beatrix;
- Matzkies, Franziska;
- Gao, Jie;
- Guo, Ying;
- Tasset, Chantal;
- Sundy, John S;
- Takeuchi, Tsutomu
Publication type:
Abstract
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial.
Published in:
Intestinal Research, 2023, v. 21, n. 1, p. 110, doi. 10.5217/ir.2021.00143
By:
- Toshifumi Hibi;
- Satoshi Motoya;
- Tadakazu Hisamatsu;
- Fumihito Hirai;
- Kenji Watanabe;
- Katsuyoshi Matsuoka;
- Masayuki Saruta;
- Taku Kobayashi;
- Feagan, Brian G.;
- Tasset, Chantal;
- Besuyen, Robin;
- Chohee Yun;
- Crans, Gerald;
- Jie Zhang;
- Akira Kondo;
- Mamoru Watanabe
Publication type:
Article
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection.
Published in:
Clinical Pharmacokinetics, 2015, v. 54, n. 8, p. 859, doi. 10.1007/s40262-015-0240-z
By:
- Namour, Florence;
- Diderichsen, Paul;
- Cox, Eugène;
- Vayssière, Béatrice;
- Aa, Annegret;
- Tasset, Chantal;
- Klooster, Gerben
Publication type:
Article
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
Published in:
2019
By:
- Genovese, Mark C.;
- Kalunian, Kenneth;
- Gottenberg, Jacques-Eric;
- Mozaffarian, Neelufar;
- Bartok, Beatrix;
- Matzkies, Franziska;
- Gao, Jie;
- Guo, Ying;
- Tasset, Chantal;
- Sundy, John S.;
- de Vlam, Kurt;
- Walker, David;
- Takeuchi, Tsutomu
Publication type:
journal article
Filgotinib: A Clinical Pharmacology Review.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 6, p. 819, doi. 10.1007/s40262-022-01129-y
By:
- Namour, Florence;
- Anderson, Kacey;
- Nelson, Cara;
- Tasset, Chantal
Publication type:
Article
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Published in:
Modern Rheumatology, 2023, v. 33, n. 4, p. 668, doi. 10.1093/mr/roac084
By:
- Tanaka, Yoshiya;
- Matsubara, Tsukasa;
- Atsumi, Tatsuya;
- Amano, Koichi;
- Ishiguro, Naoki;
- Sugiyama, Eiji;
- Yamaoka, Kunihiro;
- Combe, Bernard G.;
- Kivitz, Alan J.;
- Sang-Cheol Bae;
- Keystone, Edward C.;
- Nash, Peter;
- Genovese, Mark;
- Matzkies, Franziska;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Akira Kondo;
- Lei Ye;
- Qi Gong;
- Tasset, Chantal
Publication type:
Article
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Published in:
Modern Rheumatology, 2023, v. 33, n. 4, p. 657, doi. 10.1093/mr/roac083
By:
- Atsumi, Tatsuya;
- Tanaka, Yoshiya;
- Matsubara, Tsukasa;
- Amano, Koichi;
- Ishiguro, Naoki;
- Sugiyama, Eiji;
- Yamaoka, Kunihiro;
- Westhovens, René;
- Ching, Daniel W. T.;
- Messina, Osvaldo Daniel;
- Burmester, Gerd R.;
- Genovese, Mark;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Kondo, Akira;
- Zhaoyu Yin;
- Qi Gong;
- Chantal Tasset;
- Takeuchi, Tsutomu
Publication type:
Article
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Published in:
Modern Rheumatology, 2022, v. 32, n. 2, p. 273, doi. 10.1093/mr/roab021
By:
- Tatsuya Atsumi;
- Yoshiya Tanaka;
- Tsukasa Matsubara;
- Koichi Amano;
- Naoki Ishiguro;
- Eiji Sugiyama;
- Kunihiro Yamaoka;
- Rene;
- Westhovens;
- Ching, Daniel W.T.;
- Messina, Osvaldo Daniel;
- Burmester, Gerd R.;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Akira Kondo;
- Zhaoyu Yin;
- Ying Guo;
- Tasset, Chantal;
- Sundy, John S.;
- Tsutomu Takeuchi
Publication type:
Article
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Published in:
Modern Rheumatology, 2022, v. 32, n. 2, p. 263, doi. 10.1093/mr/roab030
By:
- Yoshiya Tanaka;
- Tsukasa Matsubara;
- Tatsuya Atsumi;
- Koichi Amano;
- Naoki Ishiguro;
- Eiji Sugiyama;
- Kunihiro YamaokaAUS-Department of Rheumatology and Infectious Diseases,Kitasato University School of Medicine, Kanagawa, Japan;
- Combe, Bernard G.;
- Kivitz, Alan J.;
- Sang-Cheol Bae;
- Keystone, Edward C.;
- Nash, Peter;
- Matzkies, Franziska;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Akira Kondo;
- Lei Ye;
- Ying Guo;
- Tasset, Chantal;
- Sundy, John S.
Publication type:
Article
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Published in:
Modern Rheumatology, 2022, v. 32, n. 1, p. 59, doi. 10.1080/14397595.2020.1859675
By:
- Tsutomu Takeuchi;
- Tsukasa Matsubara;
- Tatsuya Atsumi;
- Koichi Amano;
- Naoki Ishiguro;
- Eiji Sugiyama;
- Kunihiro Yamaoka;
- Genovese, Mark C.;
- Kalunian, Kenneth;
- Walker, David;
- Gottenberg, Jacques-Eric;
- de Vlam, Kurt;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Kondo, Akira;
- Gao, Jie;
- Ying Guo;
- Tasset, Chantal;
- Sundy, John S.;
- Yoshiya Tanakao
Publication type:
Article
Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines.
Published in:
Pediatric Allergy & Immunology, 1997, v. 8, n. 1, p. 28, doi. 10.1111/j.1399-3038.1997.tb00139.x
By:
- Oranje, Arnold P.;
- Stalder, Jean-François;
- Taïeb, Alain;
- Tasset, Chantal;
- De Longueville, Marc
Publication type:
Article

Found: 15